[Results of cooperation of Experimental and Clinical Chemotherapy, N. N. Blokhin Center for Oncology Research, Russian Academy of Medical Sciences (1952-2000)].

Milestones of the Russian antitumor chemotherapy development inseparably associated with the names of N.N. Blokhin, L.F. Larionov and V.I. Astrakhan are reviewed. Since the early 50s of the last century, more than 7,000 generic and synthetic compounds have been studied by the three generations of chemotherapy researchers. 17 antitumor drugs have been developed and passed for clinical trials, 11 of them have been or still are being used in clinic.